Factor IX Deficiency
0
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
Swedish Orphan BiovitrumMA - Waltham
1 programStandard care with blood and urine sample collectionN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Swedish Orphan BiovitrumStandard care with blood and urine sample collection
Clinical Trials (1)
Total enrollment: 550 patients across 1 trials
Natural History Study of Factor IX Treatment and Complications
Start: Jul 2015Est. completion: Dec 2021550 patients
N/AUnknown
Related Jobs
Hematology Clinical Account Manager/ Sr. Clinical Account Manager (Anaheim)
Remote
1mo ago
$94K - $226K/yr
Hematology Clinical Account Manager/ Sr. Clinical Account Manager (Raleigh)
Remote
2mo ago
$99K - $237K/yr
Hematology Clinical Account Manager/ Sr. Clinical Account Manager (San Antonio)
Remote
3mo ago
$94K - $226K/yr
Hematology Clinical Account Manager/ Sr. Clinical Account Manager (Cleveland, OH)
Remote
9mo ago
$94K - $226K/yr
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.